by Scott Milner | May 20, 2024 | Compliance, Diverson, Pharmacy, Pharmacy Supply Chain
Drug diversion in healthcare systems is a serious issue with far-reaching implications for patient safety, legal compliance, and the reputation of healthcare institutions. Over the last decade, several significant cases have highlighted the need for robust prevention...
by Scott Milner | May 16, 2024 | Compliance, Diverson, Pharmacy, Sterile Compounding, USP
I distinctly remember the stark realization of the opioid epidemic’s reach—the first time a friend succumbed to narcotic misuse, followed by the revelation of a coworker caught in active diversion. These weren’t distant, abstract events; they touched lives...
by Scott Milner | May 2, 2024 | Compliance, Diverson, Pharmacy, Sterile Compounding, USP
After years of revisions and anticipation, the compendial standards outlined in USP General Chapters <795>, <797>, and <800> became applicable as of November 1, 2023. This milestone marked a significant shift in pharmaceutical practices, especially...
